Aclara Biosciences Inc (1067588) SEC Filing 8-K Material Event for the period ending Thursday, April 29, 2004

Aclara Biosciences Inc

CIK: 1067588

View differences made from one to another to evaluate Aclara Biosciences Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Aclara Biosciences Inc.


Assess how Aclara Biosciences Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Aclara Biosciences Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2004 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
CIK: 1067588
Form Type: 8-K Corporate News
Accession Number: 0001193125-04-073057
Submitted to the SEC: Thu Apr 29 2004 8:36:09 AM EST
Accepted by the SEC: Thu Apr 29 2004
Period: Thursday, April 29, 2004
Industry: Measuring And Controlling Devices

External Resources:

Bookmark the Permalink: